URL: http://www.eutos.org/content/e58/index_eng.html

EUTOS Home  · 

EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe

The EUropean Treatment Outcome Study (EUTOS) is a collaboration between the European LeukemiaNet ELN and Novartis to improve understanding of CML, promote best practise, and enhance treatment outcomes, through 4 key projects:

• CML registry
• Molecular monitoring
• Pharmacologic monitoring
• Spread of excellence.

Major aims of the alliance are, to:

• Enhance understanding of the nature and management of CML
• Improve standardized evaluation and monitoring of treatments for CML
• Optimize treatment of CML patients across Europe

Created by: A. Hellenbrecht , generated 2007/12/19 , last changed: 2008/07/23

Printing Date: 11.03.2010   ©  2007/2008 ELIC European Leukemia Information Center